Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

导出 LinkOut

翻译打印收藏纠错

第一作者： Denis S,Fedorinov

第一单位： Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare, Moscow, Russian Federation.;City Clinical Cancer Hospital, Moscow, Russian Federation.

作者： Denis S,Fedorinov ^[1] ; Vladimir K,Lyadov ^[2] ; Dmitriy A,Sychev ^[3]

作者单位： Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare, Moscow, Russian Federation.;City Clinical Cancer Hospital, Moscow, Russian Federation. ^[1] Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare, Moscow, Russian Federation.;City Clinical Cancer Hospital, Moscow, Russian Federation.;Novokuznetsk State Institute of Postgraduate Medical Education, Novokuznetsk, Russian Federation. ^[2] Russian Medical Academy of Continuous Professional Education of the Ministry of Healthcare, Moscow, Russian Federation. ^[3]

关键词 GSTM1 GSTT1 UGT1A1 dihydropyrimidine dehydrogenase (DPYD)excision repair and cross-complementation (ERCC)fluoropyrimidines irinotecan oxaliplatin

主题词氟尿嘧啶(Fluorouracil);胃肠肿瘤(Gastrointestinal Neoplasms);基因型(Genotype);人类(Humans)

DOI 10.1515/dmpt-2021-0162

PMID 36100443

发布时间 2022-09-22

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览1

Drug metabolism and personalized therapy

2022年37卷3期

223-228页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

Drug metabolism and personalized therapy

相似文献

Drug metabolism and personalized therapy

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Genotype-based chemotherapy for patients with gastrointestinal tumors: focus on oxaliplatin, irinotecan, and fluoropyrimidines.

Drug metabolism and personalized therapy

相似文献

Drug metabolism and personalized therapy

相关期刊

检索历史清除